These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33390012)

  • 21. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting aspartate isomerization and backbone cleavage after aspartate in intact proteins by NMR spectroscopy.
    Hinterholzer A; Stanojlovic V; Regl C; Huber CG; Cabrele C; Schubert M
    J Biomol NMR; 2021 Jan; 75(1):71-82. PubMed ID: 33475951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms.
    Zhang W; Czupryn MJ
    J Pharm Biomed Anal; 2003 Jan; 30(5):1479-90. PubMed ID: 12467919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Fluorescence-Based High-Throughput Coupled Enzymatic Assay for Quantitation of Isoaspartate in Proteins and Peptides.
    Puri A; Quan Y; Narang AS; Adams M; Gandhi R; Nashine VC
    AAPS PharmSciTech; 2017 Apr; 18(3):803-808. PubMed ID: 27342117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of C-terminal residue exclusion in peptide fragmentation by ESI and MALDI tandem mass spectrometry.
    Dupré M; Cantel S; Martinez J; Enjalbal C
    J Am Soc Mass Spectrom; 2012 Feb; 23(2):330-46. PubMed ID: 22095165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions.
    Sargaeva NP; Lin C; O'Connor PB
    Anal Chem; 2009 Dec; 81(23):9778-86. PubMed ID: 19873993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and biochemical basis of the formation of isoaspartate in the complementarity-determining region of antibody 64M-5 Fab.
    Yokoyama H; Mizutani R; Noguchi S; Hayashida N
    Sci Rep; 2019 Dec; 9(1):18494. PubMed ID: 31811216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of MALDI-TOF/TOF Mass Spectrometry Approach for Quantitative Determination of Aspartate Residue Isomerization in the Amyloid-β Peptide.
    Pekov SI; Ivanov DG; Bugrova AE; Indeykina MI; Zakharova NV; Popov IA; Kononikhin AS; Kozin SA; Makarov AA; Nikolaev EN
    J Am Soc Mass Spectrom; 2019 Jul; 30(7):1325-1329. PubMed ID: 31073890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-Source Decay Characterization of Isoaspartate and β-Peptides.
    Yu X; Sargaeva NP; Thompson CJ; Costello CE; Lin C
    Int J Mass Spectrom; 2015 Nov; 390():101-109. PubMed ID: 26644780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of isoaspartic Acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry.
    Ni W; Dai S; Karger BL; Zhou ZS
    Anal Chem; 2010 Sep; 82(17):7485-91. PubMed ID: 20712325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5.
    Liu S; Moulton KR; Auclair JR; Zhou ZS
    Amino Acids; 2016 Apr; 48(4):1059-1067. PubMed ID: 26748652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative Quantitation of Beta-Amyloid Peptide Isomers with Simultaneous Isomerization of Multiple Aspartic Acid Residues by Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Ivanov DG; Indeykina MI; Pekov SI; Bugrova AE; Kechko OI; Iusupov AE; Kononikhin AS; Makarov AA; Nikolaev EN; Popov IA
    J Am Soc Mass Spectrom; 2020 Jan; 31(1):164-168. PubMed ID: 32881518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence dependent fragmentation of peptides generated by MALDI quadrupole time-of-flight (MALDI Q-TOF) mass spectrometry and its implications for protein identification.
    Wattenberg A; Organ AJ; Schneider K; Tyldesley R; Bordoli R; Bateman RH
    J Am Soc Mass Spectrom; 2002 Jul; 13(7):772-83. PubMed ID: 12148802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of MALDI-TOF/TOF-MS for relative quantitation of α- and β-Asp7 isoforms of amyloid-β peptide.
    Pekov S; Indeykina M; Popov I; Kononikhin A; Bocharov K; Kozin SA; Makarov AA; Nikolaev E
    Eur J Mass Spectrom (Chichester); 2018 Feb; 24(1):141-144. PubMed ID: 29232976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidation of chemical modifier reactivity towards peptides and proteins and the analysis of specific fragmentation by matrix-assisted laser desorption/ionization collision-induced dissociation tandem mass spectrometry.
    Rühl M; Kühn B; Roos J; Maier TJ; Steinhilber D; Karas M
    Rapid Commun Mass Spectrom; 2019 May; 33 Suppl 1():40-49. PubMed ID: 29964304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of isomerization and racemization of aspartate in the Asp-Asp motifs of a therapeutic protein.
    Zhang J; Yip H; Katta V
    Anal Biochem; 2011 Mar; 410(2):234-43. PubMed ID: 21130067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward Rapid Aspartic Acid Isomer Localization in Therapeutic Peptides Using Cyclic Ion Mobility Mass Spectrometry.
    Gibson K; Cooper-Shepherd DA; Pallister E; Inman SE; Jackson SE; Lindo V
    J Am Soc Mass Spectrom; 2022 Jul; 33(7):1204-1212. PubMed ID: 35609180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and Control of Succinimide Formation and Accumulation at Aspartic Acid Residues in The Complementarity-Determining Region of a Therapeutic Monoclonal Antibody.
    VanAernum ZL; Sergi JA; Dey M; Toner T; Kilgore B; Lay-Fortenbery A; Wang Y; Bian S; Kochert BA; Bothe JR; Gao X; Richardson D; Schuessler HA
    Pharm Res; 2023 Jun; 40(6):1411-1423. PubMed ID: 36627449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation and semiquantitative analysis of an isoaspartic acid in human alpha-Crystallin by postsource decay in a curved field reflectron.
    Yamazaki Y; Fujii N; Sadakane Y; Fujii N
    Anal Chem; 2010 Aug; 82(15):6384-94. PubMed ID: 20669993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and quantification of degradations in the Asp-Asp motifs of a recombinant monoclonal antibody.
    Xiao G; Bondarenko PV
    J Pharm Biomed Anal; 2008 May; 47(1):23-30. PubMed ID: 18201853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.